Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11568)
All Articles published online
|
Jun 21, 2010 (publication date) through Dec 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Xia XM, Wang FY, Xu WA, Wang ZK, Liu J, Lu YK, Jin XX, Lu H, Shen YZ. CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis. World J Gastroenterol 2010; 16(23): 2873-2880 [PMID: 20556832 DOI: 10.3748/wjg.v16.i23.2873] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Xia XM, Wang FY, Xu WA, Wang ZK, Liu J, Lu YK, Jin XX, Lu H, Shen YZ. CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis. World J Gastroenterol 2010; 16(23): 2873-2880 [PMID: 20556832 DOI: 10.3748/wjg.v16.i23.2873] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i23/2873.htm |
| Number | Citing Articles |
| 1 |
Dylan K. McDaniel, Kristin Eden, Veronica M. Ringel, Irving C. Allen. Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology. Inflammatory Bowel Diseases 2016; 22(9): 2265 doi: 10.1097/MIB.0000000000000858
|
| 2 |
Eva M. García-Cuesta, César A. Santiago, Jesús Vallejo-Díaz, Yasmina Juarranz, José Miguel Rodríguez-Frade, Mario Mellado. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00585
|
| 3 |
Ji-Won Park, Razanamanana H.G. Rarison, Van-Long Truong, Woo-Sik Jeong. Exploring the Therapeutic Potentials and Molecular Mechanisms of Coscinium fenestratum Alkaloids in Ulcerative Colitis: An Integrative Network Pharmacology and Molecular Docking Approach. Preventive Nutrition and Food Science 2024; 29(4): 441 doi: 10.3746/pnf.2024.29.4.441
|
| 4 |
Chien-Huang Wu, Jen-Shin Song, Kuei-Hua Chang, Jiing-Jyh Jan, Chiung-Tong Chen, Ming-Chen Chou, Kai-Chia Yeh, Ying-Chieh Wong, Chen-Tso Tseng, Szu-Huei Wu, Ching-Fang Yeh, Chung-Yu Huang, Min-Hsien Wang, Amit A. Sadani, Chun-Ping Chang, Chia-Yi Cheng, Lun K. Tsou, Kak-Shan Shia. Stem Cell Mobilizers Targeting Chemokine Receptor CXCR4: Renoprotective Application in Acute Kidney Injury. Journal of Medicinal Chemistry 2015; 58(5): 2315 doi: 10.1021/jm501769r
|
| 5 |
Mercedes Lopez‐Santalla, Marta C. Ordoñez‐Velasco, Maria Fernandez‐Garcia, Miriam Hernando‐Rodriguez, Juan A. Bueren, Rosa M. Yañez, Marina I. Garin. Improved efficacy and long‐term protective effects of CXCR4/IL10 bioengineered mesenchymal stromal cells in a model of inflammatory bowel disease. Bioengineering & Translational Medicine 2025; doi: 10.1002/btm2.70083
|
| 6 |
XIN LIU, JINYUAN MAO, CHENG HAN, SHIQIAO PENG, CHENYAN LI, TING JIN, CHENLING FAN, ZHONGYAN SHAN, WEIPING TENG. CXCR4 antagonist AMD3100 ameliorates thyroid damage in autoimmune thyroiditis in NOD.H-2h4 mice. Molecular Medicine Reports 2016; 13(4): 3604 doi: 10.3892/mmr.2016.4965
|
| 7 |
Miljana Momcilović, Marija Mostarica-Stojković, Djordje Miljković. CXCL12 in control of neuroinflammation. Immunologic Research 2012; 52(1-2): 53 doi: 10.1007/s12026-012-8282-x
|
| 8 |
Shuai Wu, Weiwei Luo, Xing Wu, Zhaohua Shen, Xiaoyan Wang. Functional Phenotypes of Peritoneal Macrophages Upon AMD3100 Treatment During Colitis-Associated Tumorigenesis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.840704
|
| 9 |
Suchada Kraiphet, Chaniphun Butryee, Anudep Rungsipipat, Sirintip Budda, Kasem Rattanapinyopitak, Siriporn Tuntipopipat. Apoptosis induced by Moringa oleifera Lam. pod in mouse colon carcinoma model. Comparative Clinical Pathology 2018; 27(1): 21 doi: 10.1007/s00580-017-2546-8
|
| 10 |
Yupei Liu, Jiao Li, Shan Tian, Qingzhi Lan, Zhiyi Sun, Chuan Liu, Weiguo Dong. Identification and validation of hub genes expressed in ulcerative colitis with metabolic dysfunction-associated steatotic liver disease. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1357632
|
| 11 |
Ryan B. Day, Daniel C. Link. Regulation of neutrophil trafficking from the bone marrow. Cellular and Molecular Life Sciences 2012; 69(9): 1415 doi: 10.1007/s00018-011-0870-8
|
| 12 |
Zhongxing Liang, Weiqiang Zhan, Aizhi Zhu, Younghyoun Yoon, Songbai Lin, Maiko Sasaki, Jan-Michael A. Klapproth, Hua Yang, Hans E. Grossniklaus, Jianguo Xu, Mauricio Rojas, Ronald J. Voll, Mark M. Goodman, Richard F. Arrendale, Jin Liu, C. Chris Yun, James P. Snyder, Dennis C. Liotta, Hyunsuk Shim, Pan-Chyr Yang. Development of a Unique Small Molecule Modulator of CXCR4. PLoS ONE 2012; 7(4): e34038 doi: 10.1371/journal.pone.0034038
|
| 13 |
Pim J. Koelink, Saskia A. Overbeek, Saskia Braber, Petra de Kruijf, Gert Folkerts, Martine J. Smit, Aletta D. Kraneveld. Targeting chemokine receptors in chronic inflammatory diseases: An extensive review. Pharmacology & Therapeutics 2012; 133(1): 1 doi: 10.1016/j.pharmthera.2011.06.008
|
| 14 |
Ishan Roy, Christopher T Veldkamp, Brian F Volkman, Michael B Dwinell. Chemokines in colitis: microRNA control. Gut 2014; 63(8): 1202 doi: 10.1136/gutjnl-2013-305886
|
| 15 |
Qin Chen, Shaosheng Bei, Zhiyun Zhang, Xiaofeng Wang, Yunying Zhu. Identification of diagnostic biomarks and immune cell infiltration in ulcerative colitis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33388-5
|
| 16 |
Stéphanie Michineau, Grégory Franck, Orianne Wagner-Ballon, Jianping Dai, Eric Allaire, Marianne Gervais. Chemokine (C-X-C Motif) Receptor 4 Blockade by AMD3100 Inhibits Experimental Abdominal Aortic Aneurysm Expansion Through Anti-Inflammatory Effects. Arteriosclerosis, Thrombosis, and Vascular Biology 2014; 34(8): 1747 doi: 10.1161/ATVBAHA.114.303913
|
| 17 |
Siddhika Pareek, Xenia Sanchenkova, Taiki Sakaguchi, Mari Murakami, Ryu Okumura, Hisako Kayama, Saya Kawauchi, Daisuke Motooka, Shota Nakamura, Daisuke Okuzaki, Tadamitsu Kishimoto, Kiyoshi Takeda. Epithelial miR‐215 negatively modulates Th17‐dominant inflammation by inhibiting CXCL12 production in the small intestine. Genes to Cells 2022; 27(4): 243 doi: 10.1111/gtc.12922
|
| 18 |
Melinda S. Hanes, Catherina L. Salanga, Arnab B. Chowdry, Iain Comerford, Shaun R. McColl, Irina Kufareva, Tracy M. Handel. Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines. Journal of Biological Chemistry 2015; 290(37): 22385 doi: 10.1074/jbc.M115.675108
|
| 19 |
Odile Wéra, Patrizio Lancellotti, Cécile Oury. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2016; 5(12): 118 doi: 10.3390/jcm5120118
|
| 20 |
Klaus Dembowsky, Barbara Romagnoli, Johann Zimmermann, Eric Chevalier, Christian Ludin, Daniel Obrecht. Novel Developments in Stem Cell Mobilization. 2012; : 303 doi: 10.1007/978-1-4614-1960-0_16
|
| 21 |
Junfei Gu, Ruolan Sun, Qiaohan Wang, Fuyan Liu, Decai Tang, Xiangwei Chang. Standardized Astragalus Mongholicus Bunge-Curcuma Aromatica Salisb. Extract Efficiently Suppresses Colon Cancer Progression Through Gut Microbiota Modification in CT26-Bearing Mice. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.714322
|
| 22 |
Xiaoying Lin, Hong Wang, Xiaolan Li. Mobilization of endothelial progenitor cells promotes angiogenesis after full thickness excision by AMD3100 combined with G-CSF in diabetic mice by SDF-1/CXCR4 axis. Diabetes and Vascular Disease Research 2021; 18(2) doi: 10.1177/14791641211002473
|
| 23 |
Miguel Camba-Gómez, Laura Arosa, Oreste Gualillo, Javier Conde-Aranda. Chemokines and chemokine receptors in inflammatory bowel disease: Recent findings and future perspectives. Drug Discovery Today 2022; 27(4): 1167 doi: 10.1016/j.drudis.2021.12.004
|
| 24 |
Renren Bai, Xiaoying Jiang, Zi Hui, Younghyoun Yoon, Jiamin Ge, Junlong Zhu, Hyunsuk Shim. Bisamide CXCR4 Modulators: Novel Anti‐IBD Agents Acting on the Chemotaxis of Inflammatory Cells. Advanced Therapeutics 2022; 5(6) doi: 10.1002/adtp.202100223
|
| 25 |
Anat Gelfand, Elazar Besser, Shiri Procaccia, Jonathan Cohen, Miryam Steinberg, Oded Kleifeld, David Meiri. Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice. Biomedicine & Pharmacotherapy 2025; 193: 118768 doi: 10.1016/j.biopha.2025.118768
|
| 26 |
Mitra Abbasifard, Vahid Mohammadi-Shahrokhi, Hossein Khorramdelazad. Stromal-derived factor-1: The glycoprotein fueling autoimmune storms via CXCR4 and CXCR7. International Journal of Biological Macromolecules 2025; 321: 146374 doi: 10.1016/j.ijbiomac.2025.146374
|
| 27 |
B. Florien Westendorp, Nikè V.J.A. Büller, Olga N. Karpus, Willemijn A. van Dop, Jan Koster, Rogier Versteeg, Pim J. Koelink, Clinton Y. Snel, Sander Meisner, Joris J.T.H. Roelofs, Anja Uhmann, Emiel Ver Loren van Themaat, Jarom Heijmans, Heidi Hahn, Vanesa Muncan, Manon E. Wildenberg, Gijs R. van den Brink. Indian Hedgehog Suppresses a Stromal Cell–Driven Intestinal Immune Response. Cellular and Molecular Gastroenterology and Hepatology 2018; 5(1): 67 doi: 10.1016/j.jcmgh.2017.08.004
|
| 28 |
Shuai Wu, Wei Yuan, Weiwei Luo, Kai Nie, Xing Wu, Xiangrui Meng, Zhaohua Shen, Xiaoyan Wang. miR‐126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis‐associated colorectal cancer. Molecular Oncology 2022; 16(19): 3465 doi: 10.1002/1878-0261.13218
|
| 29 |
Vahid Bagheri, Hossein Khorramdelazad, Gholamhossein Hassanshahi, Amir Moghadam-Ahmadi, Alireza Vakilian. CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson’s Disease. Neuroimmunomodulation 2018; 25(4): 201 doi: 10.1159/000494435
|
| 30 |
Anna K. Hartikainen, Imran Khan, Essi K. Karjalainen, Laura Renkonen-Sinisalo, Perttu Arkkila, Jonna Jalanka, Anna H. Lepistö, Reetta Satokari. Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2023.2295445
|